JP2023502387A5 - - Google Patents

Info

Publication number
JP2023502387A5
JP2023502387A5 JP2022528970A JP2022528970A JP2023502387A5 JP 2023502387 A5 JP2023502387 A5 JP 2023502387A5 JP 2022528970 A JP2022528970 A JP 2022528970A JP 2022528970 A JP2022528970 A JP 2022528970A JP 2023502387 A5 JP2023502387 A5 JP 2023502387A5
Authority
JP
Japan
Prior art keywords
antibody
seq
nos
fragment
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502387A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059604 external-priority patent/WO2021101739A1/en
Publication of JP2023502387A publication Critical patent/JP2023502387A/ja
Publication of JP2023502387A5 publication Critical patent/JP2023502387A5/ja
Pending legal-status Critical Current

Links

JP2022528970A 2019-11-19 2020-11-09 ジカウイルスを中和するヒト抗体およびその使用方法 Pending JP2023502387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962937603P 2019-11-19 2019-11-19
US62/937,603 2019-11-19
PCT/US2020/059604 WO2021101739A1 (en) 2019-11-19 2020-11-09 Human antibodies that neutralize zika virus and methods of use therefor

Publications (2)

Publication Number Publication Date
JP2023502387A JP2023502387A (ja) 2023-01-24
JP2023502387A5 true JP2023502387A5 (enExample) 2023-11-06

Family

ID=75980179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528970A Pending JP2023502387A (ja) 2019-11-19 2020-11-09 ジカウイルスを中和するヒト抗体およびその使用方法

Country Status (8)

Country Link
US (1) US20230085393A1 (enExample)
EP (1) EP4061422A4 (enExample)
JP (1) JP2023502387A (enExample)
KR (1) KR20220103761A (enExample)
CN (1) CN115135345A (enExample)
BR (1) BR112022009574A2 (enExample)
CA (1) CA3158401A1 (enExample)
WO (1) WO2021101739A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY35620A (es) * 2013-06-21 2015-01-30 Novartis Ag Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso
WO2018010789A1 (en) * 2016-07-13 2018-01-18 Humabs Biomed Sa Novel antibodies specifically binding to zika virus epitopes and uses thereof
EP3534953A4 (en) * 2016-11-02 2020-10-07 Vanderbilt University ANTIBODIES AGAINST HUMAN ZIKA VIRUS AND THEIR USE PROCEDURES
US11370830B2 (en) * 2017-04-07 2022-06-28 The Rockefeller University Neutralizing antibodies that bind to the zika virus domain III envelope region

Similar Documents

Publication Publication Date Title
JP2022541652A5 (enExample)
JP2023518849A5 (enExample)
CN111995672B (zh) 冠状病毒sars-cov-2 s蛋白特异性抗体及其用途
CN111978397B (zh) 特异性结合sars-cov-2 s蛋白的抗体及其用途
JP2022513075A5 (enExample)
CN112010962B (zh) 用于检测covid-19的抗体及其医学用途
JP2022542699A5 (enExample)
JP6055763B2 (ja) ヒトサイトメガロウイルス（ＣＭＶ）ｇＢタンパク質に対する高親和性ヒト抗体
CN114195886A (zh) 抗hpv39 l1蛋白单克隆抗体及其制备与应用
CN113549147B (zh) 抗柯萨奇a6型病毒的单克隆抗体及其应用
WO2022065445A1 (ja) ＳＡＲＳ－ＣｏＶ－２中和抗体又はその断片
CN116655785A (zh) 一种抑制寨卡病毒感染的单克隆抗体及其应用
JP2023502387A5 (enExample)
CN114605539A (zh) 人源化的抗IL-4Rα单域抗体及其应用
CN109295002B (zh) 杂交瘤细胞、单克隆抗体及其制备方法和应用
CN112778413A (zh) 抗水痘-带状疱疹病毒的抗体
CN110964104B (zh) 可结合hpv18病毒的蛋白质及其应用
CN109206510B (zh) 与伪狂犬病病毒gB蛋白结合的单克隆抗体及其应用
CN114230659A (zh) 抗hpv53 l1蛋白单克隆抗体及其制备与应用
CN111153990B (zh) 针对Echo30的单克隆抗体、制备方法及其应用
CN117229392B (zh) 抗非洲猪瘟病毒p72蛋白中和活性单克隆抗体5a8及其应用
CN114773461B (zh) 乙型脑炎病毒抗体1d11及其应用
CN117384278A (zh) 抗非洲猪瘟病毒p72蛋白中和活性单克隆抗体3f1及其应用
WO2022079359A1 (en) Sars-cov-2 coronavirus-neutralizing antibody
CN113549146B (zh) 针对柯萨奇病毒b1型的单克隆抗体及其用途